Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
A Phase I Study of Recombinant Adenovirus Vector-Mediated Delivery of an Anti-erbB-2 Single-Chain (sFv) Antibody Gene for Previously Treated Ovarian and Extraovarian Cancer Patients. University of Alabama at Birmingham,Birmingham,Alabama